By Jeanne Whalen
The Wall Street Journal Europe
02 Jul 2007
Sanofi-Aventis said it is withdrawing its application to sell the obesity drug rimonabant in the U.S. but plans to resubmit it at a future date, admitting the defeat, for now, of what it hoped would be a blockbuster medicine. The move comes two weeks... read more...
posted by Bank Report at
1:15 PM
0 Comments:
Post a Comment
<< Home